Trials / Unknown
UnknownNCT00921596
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass (CPB)
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass, a Single Center's Experience
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Conventional cardiac operations are performed with median sternotomy, which is related to great wound, morbidities, longer duration in hospital and most significantly, cosmetic problems. The investigators invested a new minimally invasive cardiac operation method totally under video-endoscope and peripheral cardiopulmonary bypass. The investigators' hypothesis is that this new minimally method could provide better cosmetic effects to the patients, and also relate to shorter postoperative hospital stay and better recovery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cardiac operation with totally endoscopic method | Cardiac operations are performed with three keyholes in the right chest wall. Video images are obtained by digital thoracoscope through one hole. Intracardiac lesions are accessed with surgical instruments and repaired through the other two holes. Cardiopulmonary bypass is set up with femoral cannulations. Moderate system hypothermic is applied for the operation. Cardiac arrest is achieved with ascending aorta clamp and cardioplegia solution delivery through aortic root cannulation. After the intracardiac lesions are repaired, aortic clamp is removed, and the heart is reperfused to restore its spontaneous rhythm. After the patients are rewarmed to normal temperature, CPB is discontinued. Femoral cannulations are removed, and surgical wounds are closed. |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-06-16
- Last updated
- 2009-06-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00921596. Inclusion in this directory is not an endorsement.